Market revenue in 2023 | USD 227.3 million |
Market revenue in 2030 | USD 381.8 million |
Growth rate | 7.7% (CAGR from 2023 to 2030) |
Largest segment | Outsourcing |
Fastest growing segment | Outsourcing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In-house, Outsourcing |
Key market players worldwide | Genpact Ltd, Criterium Inc., Icon PLC, Wuxi AppTec Co Ltd, Medpace Holdings Inc, Charles River Laboratories International Inc, Labcorp Holdings Inc, FREYR Battery Inc, Pharmexon, Cambridge Design Partnership, Voisin Consulting Life Sciences, Accell, PAREXEL, Promedica International, PharmaLex, NDA Regulatory Service GmbH, QVigilance, BlueReg Group |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to regulatory affairs market will help companies and investors design strategic landscapes.
Outsourcing was the largest segment with a revenue share of 58.12% in 2023. Horizon Databook has segmented the Australia regulatory affairs market based on in-house, outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
In Australia, there are nearly 400 domestic biotechnology, 500 Med Tech, and 50 multinational companies operating as subsidiaries, such as Pfizer, GSK, Bristol-Myers Squibb, Merck, & Novartis. Presence of several local and foreign companies is anticipated to boost demand for various regulatory services, thereby fueling market growth.
Furthermore, aligning of Good Manufacturing Practices across various jurisdictions in the country owing to regulatory agreements between the Therapeutic Goods Administration (TGA) in Australia, the U.S. FDA, and the European Medicines Agency is anticipated to facilitate market entry of U.S. & European firms, which is likely to facilitate market growth.
The medical device industry in the country is heavily dependent on imports, wherein about 80.0% of medical supplies’ demand is met through imports. The exporters must appoint an Australian representative or sponsor to obtain regulatory approval in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia regulatory affairs market , including forecasts for subscribers. This country databook contains high-level insights into Australia regulatory affairs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account